Suppr超能文献

基于热敏共聚物水凝胶的干细胞移植介导的梗死心肌修复增强

Enhanced infarct myocardium repair mediated by thermosensitive copolymer hydrogel-based stem cell transplantation.

作者信息

Xia Yu, Zhu Kai, Lai Hao, Lang Meidong, Xiao Yan, Lian Sheng, Guo Changfa, Wang Chunsheng

机构信息

Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China Shanghai Institute of Cardiovascular Disease, Shanghai 200032, P. R. China Department of Cardio-Thoracic Surgery, Affiliated Hospital of Zunyi Medical College, Zunyi 563003, P. R. China.

Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China Shanghai Institute of Cardiovascular Disease, Shanghai 200032, P. R. China.

出版信息

Exp Biol Med (Maywood). 2015 May;240(5):593-600. doi: 10.1177/1535370214560957. Epub 2014 Nov 27.

Abstract

Mesenchymal stem cell (MSC) transplantation by intramyocardial injection has been proposed as a promising therapy strategy for cardiac repair after myocardium infarction. However, low retention and survival of grafted MSCs hinder its further application. In this study, copolymer with N-isopropylacrylamide/acrylic acid/2-hydroxylethyl methacrylate-poly(ɛ-caprolactone) ratio of 88:9.6:2.4 was bioconjugated with type I collagen to construct a novel injectable thermosensitive hydrogel. The injectable and biocompatible hydrogel-mediated MSC transplantation could enhance the grafted cell survival in the myocardium, which contributed to the increased neovascularization, decreased interstitial fibrosis, and ultimately improved heart function to a significantly greater degree than regular MSC transplantation. We suggest that this novel hydrogel has the potential for future stem cell transplantation.

摘要

心肌内注射间充质干细胞(MSC)已被提议作为心肌梗死后心脏修复的一种有前景的治疗策略。然而,移植的MSC保留率低和存活率低阻碍了其进一步应用。在本研究中,将N - 异丙基丙烯酰胺/丙烯酸/甲基丙烯酸2 - 羟乙酯 - 聚(ε - 己内酯)比例为88:9.6:2.4的共聚物与I型胶原进行生物共轭,构建了一种新型的可注射热敏水凝胶。这种可注射且具有生物相容性的水凝胶介导的MSC移植可提高移植细胞在心肌中的存活率,这有助于增加新生血管形成、减少间质纤维化,并最终比常规MSC移植在更大程度上显著改善心脏功能。我们认为这种新型水凝胶在未来干细胞移植方面具有潜力。

相似文献

7
Hemodynamic contribution of stem cell scaffolding in acute injured myocardium.急性损伤心肌中干细胞支架的血液动力学贡献。
Tissue Eng Part A. 2012 Aug;18(15-16):1652-63. doi: 10.1089/ten.TEA.2011.0591. Epub 2012 Jun 25.

引用本文的文献

2
Application of Hydrogels in Cardiac Regeneration.水凝胶在心脏再生中的应用。
Cardiol Ther. 2023 Dec;12(4):637-674. doi: 10.1007/s40119-023-00339-0. Epub 2023 Nov 18.
5
Translational Applications of Hydrogels.水凝胶的转化应用。
Chem Rev. 2021 Sep 22;121(18):11385-11457. doi: 10.1021/acs.chemrev.0c01177. Epub 2021 May 3.
6
Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.用于心血管疾病的基于水凝胶的可注射纳米复合材料
Front Bioeng Biotechnol. 2020 Mar 31;8:251. doi: 10.3389/fbioe.2020.00251. eCollection 2020.
10
Injectable Hydrogels for Cardiac Tissue Engineering.注射型水凝胶在心脏组织工程中的应用
Macromol Biosci. 2018 Jun;18(6):e1800079. doi: 10.1002/mabi.201800079. Epub 2018 May 7.

本文引用的文献

4
Development of new technologies for stem cell research.干细胞研究新技术的发展。
J Biomed Biotechnol. 2012;2012:741416. doi: 10.1155/2012/741416. Epub 2012 Nov 26.
8
Intramyocardial, autologous CD34+ cell therapy for refractory angina.心肌内自体 CD34+ 细胞治疗难治性心绞痛。
Circ Res. 2011 Aug 5;109(4):428-36. doi: 10.1161/CIRCRESAHA.111.245993. Epub 2011 Jul 7.
9
Myocardial regeneration: Roles of stem cells and hydrogels.心肌再生:干细胞和水凝胶的作用。
Adv Drug Deliv Rev. 2011 Jul 18;63(8):688-97. doi: 10.1016/j.addr.2011.02.007. Epub 2011 Mar 1.
10
Cardiac cell therapy: lessons from clinical trials.心脏细胞治疗:临床试验的经验教训。
J Mol Cell Cardiol. 2011 Feb;50(2):258-65. doi: 10.1016/j.yjmcc.2010.06.010. Epub 2010 Jun 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验